QIAGEN - 25 Year Stock Price History | QGEN

Historical daily share price chart and data for QIAGEN since 1996 adjusted for splits. The latest closing stock price for QIAGEN as of December 06, 2021 is 53.38.
  • The all-time high QIAGEN stock closing price was 59.58 on July 17, 2000.
  • The QIAGEN 52-week high stock price is 59.00, which is 10.5% above the current share price.
  • The QIAGEN 52-week low stock price is 45.58, which is 14.6% below the current share price.
  • The average QIAGEN stock price for the last 52 weeks is 51.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
QIAGEN Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 51.5291 53.3100 56.8300 46.2500 53.3800 1.00%
2020 44.6405 33.9300 54.7400 33.1700 52.8500 56.36%
2019 37.0654 34.1300 43.1000 25.4100 33.8000 -1.89%
2018 35.1436 31.3600 39.3900 31.0100 34.4500 11.38%
2017 31.4871 29.3043 35.3700 27.8100 30.9300 6.30%
2016 25.1390 27.7362 29.7196 20.9657 29.0966 1.34%
2015 26.4008 24.2679 29.2939 23.1672 28.7124 17.86%
2014 23.9161 24.4341 26.1475 20.7788 24.3614 -1.47%
2013 21.6469 19.5016 25.5971 19.1589 24.7248 31.19%
2012 17.4977 14.7040 19.9377 14.7040 18.8471 31.42%
2011 17.9318 20.6127 22.8764 13.1360 14.3406 -29.36%
2010 21.1574 23.5306 24.9013 17.6739 20.3011 -12.45%
2009 19.5696 17.7674 24.0187 15.3998 23.1880 27.16%
2008 20.1349 22.5961 24.2887 13.4060 18.2347 -16.58%
2007 18.9263 16.2409 24.4548 15.9086 21.8588 39.13%
2006 14.8945 12.5026 16.7705 12.1703 15.7113 28.77%
2005 12.6613 11.4538 14.2991 10.9657 12.2015 7.31%
2004 12.0099 12.7934 16.2098 9.0758 11.3707 -8.44%
2003 9.1966 5.6906 13.3437 5.3998 12.4195 130.44%
2002 11.3741 19.7508 21.6096 4.6833 5.3894 -72.04%
2001 23.1759 36.3448 36.7394 12.8557 19.2731 -46.34%
2000 41.6231 21.2876 59.5846 19.5353 35.9190 83.26%
1999 11.2352 8.5021 21.6771 8.5021 19.6002 150.62%
1998 7.6377 5.8255 9.8650 5.4361 7.8206 35.03%
1997 5.2751 3.2944 7.6584 3.1477 5.7918 73.28%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.357B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.010B 7.90
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90